Relevance of image fusion with MRI for the interpretation of I-123 iodo-methyl-tyrosine scans in patients with suspected recurrent or residual brain tumor

Clinical Nuclear Medicine

Volumn 31, Issue 4, 2006, Pages 189-192

  Amthauer, Holger ^a   Wurm, Reinhard ^a   Kuczer, David ^a   Ruf, Juri ^a   Michel, Roger ^a   Eisenacher, Julia ^a   Stockhammer, Florian ^a   Denecke, Timm ^a   Felix, Roland ^a   Plotkin, Michail ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

3 I 123 iodo methyl L tyrosine; Image fusion; MRI; SPECT

Indexed keywords

IODINE 123; IODOMETHYLTYROSINE I 123; UNCLASSIFIED DRUG; 3 IODO ALPHA METHYLTYROSINE; 3-IODO-ALPHA-METHYLTYROSINE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; METIROSINE; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN STEM; BRAIN TUMOR; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; GLIOMA; HEMISPHERE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR RECURRENCE; ADOLESCENT; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PATHOLOGY; RETROSPECTIVE STUDY; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; METHYLTYROSINES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33745088009     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000204198.07230.6c     Document Type: Article

References (27)

1. Bergström M, Collins VP, Ehrin E, et al. Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. J Comput Assist Tomogr. 1983;7:1062-1066.
2. Tovi M, Lilja A, Bergstrom M, et al. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiol. 1990;31:417-429.
3. Lilja A, Lundqvist H, Olsson Y, et al. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions. Acta Radiol. 1989;30:121-128.
4. 123I]iodo-α-methyl tyrosine and SPECT. J Nucl Med. 1989;30:110-112.
5. Langen KJ, Cohnen HH, Roosen N, et al. SPECT studies of brain tumors with L-3-[123]iodo-α-methyltyrosine: comparison with PET, 124IMT and first clinical results. J Nucl Med. 1990;31:281-286.
6. 11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med. 1997;38:517-522.
7. Langen K-J, Clauss RP, Holschbach M, et al. Comparison of iodotyrosines and methionine uptake in a rat glioma model. J Nucl Med. 1998;39:1596-1599.
8. Pauleit D, Floeth F, Tellmann L, et al. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-α-methyl-L-tyrosine SPECT in brain tumors. J Nucl Med. 2004;45:374-381.
9. Samnick S, Bader JB, Hellwig D, et al. Clinical value of iodine-alpha-methyl-L-thyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up. J Clin Oncol. 2002;20:396-404.
10. Kuwert T, Woesler B, Morgenroth C, et al. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. J Nucl Med. 1998;39:23-27.
11. 1H MR-spectroscopy at 3.0 Tesla in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol. 2004;70:49-58.
12. Matheja P, Weckesser M, Rickert CH, et al. I-123-lodo-alpha-methyl tyrosine SPECT in non-parenchymal brain tumours. Nuklearmedizin. 2002;41:191-196.
13. Plotkin M, Amthauer H, Eisenacher J, et al. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours. Neuroradiology. 2005;47:18-26.
14. 123I-Iodo-α-methyltyrosine uptake in brain tumor recurrences. Nuklearmedizin. 1995;34:71-75.
15. Hutton BR, Braun M, Zhurfjell L, Lau DY. Image registration: an esential tool for nuclear medicine. Eur J Nucl Med Mol Imag. 2002;29:559-577.
16. Amthauer H, Ruf J, Bohmig M, et al. Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit? Eur J Nucl Med Mol Imag. 2004;31:342-348.
17. Ruf J, Lopez Hänninen E, Steinmüller T, et al. Use of MRI, scintigraphy and image fusion for the preoperative localization of parathyroid glands. Nuklearmedizin. 2004;43:85-90.
18. Ruf J, Lehmkuhl L, Bertram H, et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun. 2004;25:1177-1182.
19. Kaczirek K, Prager G, Kienast O, et al. Combined transmission and (99m)Tc-sestamibi emission tomography for localization of mediastinal parathyroid glands. Nuklearmedizin. 2003;42:220-223.
20. Chang L. A method for attenuation correction in computed tomography. IEEE Trans Nucl Sci. 1978;25:638-643.
21. Pietrzyk U, Herholz K, Fink G, et al. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med. 1994;35:2011-2018.
22. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61-77.
23. Plotkin M, Hautzel H, Krause BJ, et al. Fluorine-18-labeled fluorodeoxyglucose-positron emission tomography studies of acute brainstem Lyme neuroborreliosis. J Neurosurg. 2005;102:927-929.
24. Amthauer H, Eisenacher J, Plotkin M, et al. Relevancy of image fusion with MR imaging for the interpretation of 3-[123]iodo-alpha-methyl-L-tyrosine brain SPECT. Eur J Nucl Med Mol Imag. 2004;31(suppl):P293.
25. Wong TZ, Turkington TG, Hawek TC, et al. PET and brain tumor image fusion. Cancer J. 2004;10:234-242.
26. Paulino AC, Thorstad WL, Fox T. Role of fusion in radiotherapy treatment planning. Semin Nucl Med. 2003;33:238-243.
27. Grosu AL, Feldmann H, Dick S, et al. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas. Int J Radiat Oncol Phys. 2002;54:842-854.